Isonics Corporation to Exhibit at SEMICON Europa 1999
Jump to first matched term
GOLDEN, Colo., March 15 /PRNewswire/ -- Isonics Corporation (OTC Bulletin Board: ISON) announced
today that it will exhibit its isotopically pure silicon-28 wafers at SEMICON Europa 1999 in Munich,
Germany, April 13 - 15, 1999. Silicon-28 wafers, manufactured exclusively by Isonics, exhibit higher
thermal conductivity characteristics than wafers manufactured using natural silicon.
Established to promote global business opportunities for semiconductor equipment, material and service
suppliers, SEMICON Europa is the largest international conference and exposition specific to the
industry. The show is particularly important for Isonics in that approximately one-half of their revenues
come from their German subsidiary ChemoTrade and much of their materials manufacturing operations
are located in Eastern Europe.
Isonics' ultra-pure wafers are composed of in isotopically pure silicon-28 layer epitaxially grown on a
standard silicon single-crystal wafer. Recent tests have shown that isotopically pure silicon-28 has greater
than 50 percent higher thermal conductivity than natural silicon. The Company believes that the improved
thermal characteristics of isotopically pure silicon-28 will facilitate the manufacture of higher density
integrated circuits resulting in increased performance and improved chip yields. The elegance of
isotopically pure silicon-28 is that while it has better properties than standard silicon, it can be used
without any changes in existing silicon semiconductor manufacturing processes. The Company is also
working to provide bulk wafers made entirely of higher thermal conductivity silicon-28.
At SEMICON Europa, Isonics will be exhibiting a computer model developed by Dr. Peter Raad from
Southern Methodist University which demonstrates the peak temperature reduction possible due to the
higher thermal conductivity of silicon-28 wafers.
You can find Isonics in Booth #B2-105.
Isonics is an advanced materials and technology company which develops and commercializes products
based on enriched stable isotopes. Stable isotopes can be thought of as ultra-ultra pure materials. This
high degree of purification provides enhanced performance properties compared to normal materials.
Stable isotopes have commercial uses in several areas, including energy; research, medical diagnostics,
and drug development; product tagging and stewardship; semiconductors; lasers; and optical materials.
Except for historical information contained herein, this document contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. The statements involve known
and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be
materially different from those anticipated and discussed herein. Further, the Company operates in
industries where securities values may be volatile and may be influenced by regulatory and other factors
beyond the Company's control. Other important factors that the Company believes might cause such
differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April
30, 1998 filed with the Securities and Exchange Commission. In assessing forward-looking statements
contained herein, readers are urged to carefully read all cautionary statements Contained in the
Company's filings with the Securities and Exchange Commission.
SOURCE Isonics Corporation
/CONTACT: Matt Clawson of Allen & Caron, Inc., 714-957-8440, for Isonics;
or James E. Alexander of Isonics Corporation, 303-279-7900/
|
